EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCLAG00000010980
Gene Symbol: GUCY1A1
3 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCLAG00000017060
Gene Symbol: GUCY1A2
2 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCLAG00000011034
Gene Symbol: GUCY1B1
2 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSCLAG00000004637
Gene Symbol: HSP90AA1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSCLAG00000015740
Gene Symbol: HSP90AB1
3 Cross references
198 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSCLAG00000003343
Gene Symbol: HMGB1
3 Cross references
250 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSCLAG00000017680
Gene Symbol: HRH1
2 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSCLAG00000015189
Gene Symbol: HRH2
2 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSCLAG00000005909
Gene Symbol: HRH3
3 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSCLAG00000009200
Gene Symbol: HRH4
2 Cross references
105 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSCLAG00000010112
Gene Symbol: HDAC1
2 Cross references
276 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSCLAG00000017266
Gene Symbol: HDAC10
2 Cross references
181 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).